Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05504265
PHASE2/PHASE3

Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

View on ClinicalTrials.gov

Summary

This study was designed to compare analgesic efficacy and safety of different perioperative analgesic modes in minimally invasive esophagectomy for esophageal cancer.

Official title: Comparison of Efficacy and Safety of Different Analgesic Modes in Minimally Invasive Esophagectomy for Esophageal Cancer

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

102

Start Date

2022-10-10

Completion Date

2025-12-20

Last Updated

2025-03-20

Healthy Volunteers

No

Interventions

DRUG

Preemptive flurbiprofen axetil

50mg once,30min before induction anesthesia

DRUG

Postoperative flurbiprofen axetil

50mg bid

DEVICE

Patient-controlled analgesia pump

Sufentanil 2.5 μg/kg+ondansetron 8mg, prepared to 100ml normal saline; background dose: 2 ml/h, single press analgesic pump injection volume: 0.5 ml, locking time: 15 min.

Locations (1)

Cancer Hospital Chinese Academy of Medical Sciences

Beijing, China